Bridgeway Capital Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Bridgeway Capital Management's EDIT Position: Q3 2026 in Review
Bridgeway Capital Management reduced its Editas Medicine (EDIT) stake by 1.7% in Q3 2026, selling an estimated $6.21K and leaving 123,882 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #905.
Bridgeway Capital Management first reported a position in EDIT in Q4 2024 and has held it in 8 quarters since. The position peaked at $408K in Q2 2026. 221 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Bridgeway Capital Management held 123,882 shares of Editas Medicine worth $318K as of Q3 2026.
- Bridgeway Capital Management sold 2,118 Editas Medicine shares in Q3 2026, an estimated $6.21K.
- Editas Medicine made up 0.01% of Bridgeway Capital Management's portfolio in Q3 2026, its #905 holding.
- Bridgeway Capital Management first reported a position in Editas Medicine in Q4 2024 and has held it in 8 quarters since.
- Bridgeway Capital Management's Editas Medicine position peaked at $408K in Q2 2026.
- 221 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.